• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006

0
  • by alexperjescuadmin
  • in Cardiovascular
  • — 15 Nov, 2006
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
AudioMedica News
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
00:00 /
RSS Feed
Share
Link
Embed
Joseph Muhlestein
Joseph Muhlestein
Sidney Smith
Sidney Smith
Joost Daemen
Joost Daemen

Drug Eluting Stents: More Deaths in Real World Use

REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract: 2225
JOSEPH MUHLESTEIN, University of Utah , Salt Lake City
Extended follow up of 11 000 patients who received drug eluting stents outside the context of clinical trials (in the “real world”) has found an increase in deaths, especially caused by complications in “non-target lesions” – coronary vessels or segments of a vessels which were not the target of the original angioplasty. Joseph Muhlestein told the AHA meeting this seems to be a real consequence of the drug eluting stents and not just the result of selection.

Drug Eluting Stents; Anti Platelet Therapy: Latest Recommendations

REFERENCE: American Heart Association Scientific Sessions, Chicago, November 12-15, 2006. Abstract: 3236; 2225; 2498
SIDNEY SMITH, University of North Carolina, Chapel Hill
Comments on the new findings about drug eluting stents were made during the AHA meeting by Sidney Smith who also gave conference delegates an update on the latest AHA thinking about stent guidelines and also latest recommendations for antiplatelet therapy following angioplasty.

Sirolimus and Paclitaxel Eluting Stents Not Superior to Bare Metal in Patients with Acute Myocardial Infarction After Three Years

American Heart Association Scientific Sessions 2006 November 12-15th Chicago, Illinois. Abstract: 2498
JOOST DAEMEN, Erasmus Medical Center, Rotterdam
Do drug-eluting stents remain superior to bare metal stents after three years follow-up? No, according to Joost Daemen and his group from Rotterdam who told the AHA that both sirolimus and paclitaxel eluting stents don’t bring better long-term outcomes for patients with ST-elevation myocardial infarction. At the AHA conference he discussed his findings with Sarah Maxwell.

[audio:https://www.audiomedica.com/podcasting/aha/061114AHA3rdPodcast.mp3]
Share

Tags: drug-elutinginhibitorstents

You may also like...

  • Withholding Abciximab Infusion After Stenting Withholding Abciximab Infusion After Stenting 17 Nov, 2005
  • Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study 6 Nov, 2007
  • Statins and ARBs: a Special Combination? Statins and ARBs: a Special Combination? 17 Nov, 2005
  • Telomere Length Predicts Coronary Heart Disease Risk and Statin Response Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006
  • Next story Audio Journal of Oncology in Advance – November 15th, 2006
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • ALK—Targeted Lung Cancer Drugs Benefited Real…
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths…
  • Home
  • Cardiovascular
  • Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.